Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1

Archives of Surgery

Volumn 140, Issue 4, 2005, Pages 374-382

  Lambert, Laura A ^a   Shapiro, Suzanne E ^a   Lee, Jeffrey E ^a   Perrier, Nancy D ^a   Truong, Mylene ^a   Wallace, Michael J ^a   Hoff, Ana O ^a   Gagel, Robert F ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DNA; PARATHYROID HORMONE;

ADULT; CARCINOID; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FOLLOW UP; GASTRINOMA; GENE; GENE MUTATION; HOARSENESS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOPHYSIS TUMOR; MALE; MEN1 GENE; MORBIDITY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PARATHYROIDECTOMY; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REOPERATION; SURGICAL APPROACH; THYMECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 16844369155     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.140.4.374     Document Type: Conference Paper

References (35)

1. Arnalsteen LC, Alesina PF, Quiereux JL, et al. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2002;132:1119-1124; discussion, 1124-1115.
2. Hellman P, Skogseid B, Oberg K, Juhlin C, Akerstrom G, Rastad J. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery. 1998;124:993-999.
3. Elaraj DM, Skarulis MC, Libutti SK, et al. Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery. 2003;134:858-864.
4. Kivlen MH, Bartlett DL, Libutti SK, et al. Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery. 2001;130:991-998.
5. Brandi ML, Gagel RF, Angelt A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671.
6. Sato M, Matsubara S, Miyauchi A, et al. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. J Med Genet. 1998;35:915-919.
7. Diagnosis and management of asymptomatic primary hyperparathyroidism: National Institutes of Health Consensus Development Conference, October 29-31, 1990. Consens Statement. 1990;87:1-18.
8. Mihai R, Farndon JR. Familial endocrine disease: genetics and early treatment. In: Farndon JR, ed. Breast and Endocrine Surgery. 2nd ed. Philadelphia, Pa: WB Saunders Co; 2001:137-168.
9. Burgess JR, David R, Greenaway TM, Parameswaran V, Shepherd JJ. Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy. Arch Surg. 1999;134:1119-1123.
10. Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg. 2002;137:641-647.
11. Lumachi F, Tregnaghi A, Zucchetta P, et al. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Br J Radiol. 2004;77:100-103.
12. Lumachi F, Zucchetta P, Tregnaghi A, et al. Noninvasive parathyroid imaging in primary hyperparathyroidism. Ann Ital Chir. 2003;74:385-388.
13. Weber AL, Randolph G, Aksoy FG. The thyroid and parathyroid glands: CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am. 2000;38:1105-1129.
14. Tonelli F, Spini S, Tommasi M, et al. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. World J Surg. 2000;24:556-562.
15. Weber KJ, Lee J, Decresce R, Subhasis M, Prinz R. Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Paper presented at: 25th Annual AAES Meeting; April 6, 2004; Charlottesville, Va.
16. Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308-320.
17. Estella E, Leong MS, Bennett I, et al. Parathyroid hormone venous sampling prior to reoperation for primary hyperparathyroidism. A N Z J Surg. 2003;73:800-805.
18. Selby PL, Peacock M. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. N Engl J Med. 1986;314:1481-1485.
19. Marcus R. Rational approaches to osteoporosis therapy. Adv Pharmacol. 1991;22:29-55.
20. Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. J Bone Miner Res. 2001;16:113-119.
21. Khan AA, Bilezikian JP, Kung AW, et al. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3319-3325.
22. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab. 2003;88:5644-5649.
23. Harman CR, Grant CS, Hay ID, et al. Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery. 1998;124:1011-1019; discussion; 1019-1020.
24. Demeter JG, De Jong SA, Lawrence AM, Paloyan E. Recurrent hyperparathyroidism due to parathyroid autografts: incidence, presentation, and management. Am Surg. 1993;59:178-181.
25. Jansson S, Tisell LE. Autotransplantation of diseased parathyroid glands into subcutaneous abdominal adipose tissue. Surgery. 1987;101:549-556.
26. Mallette LE, Blevins T, Jordan PH, Noon GP. Autogenous parathyroid grafts for generalized primary parathyroid hyperplasia: contrasting outcome in sporadic hyperplasia versus multiple endocrine neoplasia type I. Surgery. 1987;101:738-745.
27. Wells SA Jr, Farndon JR, Dale JK, Leight GS, Dilley WG. Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 1980;192:451-458.
28. Feldman AL, Sharaf RN, Skarulis MC, et al. Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery. 1999;126:1042-1048.
29. D'Avanzo A, Parangi S, Morita E, Duh QY, Siperstein AE, Clark OH. Hyperparathyroidism after thyroid surgery and autotransplantation of histologically normal parathyroid glands. J Am Coll Surg. 2000;190:546-552.
30. Rattner DW, Marrone GC, Kasdon E, Silen W. Recurrent hyperparathyroidism due to implantation of parathyroid tissue. Am J Surg. 1985;149:745-748.
31. Spiegel AM, Downs RW Jr, Santora A, Marx SJ, Doppman J, Shull J. Persistent hyperparathyroidism caused by incomplete parathyroid resection and a hyperfunctioning parathyroid autograft. JAMA. 1983;250:1896-1898.
32. Wells SA Jr, Ross AJ III, Dale JK, Gray RS. Transplantation of the parathyroid glands: current status. Surg Clin North Am. 1979;59:167-177.
33. Brandi ML, Aurbach GD, Fitzpatrick LA, et al. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med. 1986;314:1287-1293.
34. Marx SJ, Sakaguchi K, Green J III, Aurbach GD, Brandi ML. Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 1988;67:149-153.
35. Hickey RC, Samaan NA. Human parathyroid autotransplantation: proved function by radioimmunoassay of plasma parathyroid hormone. Arch Surg. 1975;110:892-895.